Search results
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 7 days ago, opens new tab on Thursday raised its annual profit and revenue forecast on the back of strong...
What to Know About Breast Cancer Screening Guidelines
Time via Yahoo News· 1 day agoThat requirement will apply to all mammography facilities beginning this September, after the U.S....
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
Investor's Business Daily· 7 days ago-based drugmaker reported almost $5.11 billion in sales of its cancer drugs. Sales rocketed 23% on a...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda By Reuters
Investing.com· 7 days agoKeytruda, the world's top selling drug in 2023, has been Merck's key revenue driver over the past...
GSK raises profit outlook on strong vaccine, HIV drug sales By Reuters
Investing.com· 1 day agoCEO Emma Walmsley's strategy has focussed on vaccines, cancer and infectious diseases and a shift in...
These Are the Drugs America Is Running Short On
247wallst.com· 3 days agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
DEA may reclassify marijuana as a Schedule III drug. What would that mean for Georgia?
The Augusta Chronicle via Yahoo News· 14 hours agoWith a Schedule I drug, depending on the amount of the possession, the punishment could be up to 15 years. Is marijuana legal in Georgia? ... Low THC Registry card and only ...
Cancer drugs help drive AstraZeneca sales sharply higher
PA Media: Money via Yahoo Finance· 7 days agoAstraZeneca revealed soaring sales over the latest quarter as it was boosted by its cancer drugs....
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via AOL· 7 days ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecast on the back of...
First trial over Zantac cancer claims set to begin in Chicago
WHTC 1450 Holland· 1 day agoBy Brendan Pierson (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac,...